A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₩277,422.8, with a 24-hour trading volume of ₩476.23M. The asset's market cap is ₩430.15T, after moving 1.25% in the last day.
Tokenized AstraZeneca PLC is trading at ₩136,913.5, with a tokenized market cap of ₩77.51B and a 24-hour trading volume of ₩934.18M. The tokenized asset has moved -11.72% in the past 24 hours.